Skip to Main Content

Paper Details

INCIDENCE AND RISK FACTORS OF INTRAOCULAR INFLAMMATION AFTER BROLUCIZUMAB TREATMENT IN JAPAN: A Multicenter Age-Related Macular Degeneration Study.
Retina
2
2024
Author NameAffiliation
Yasuo YanagiYokohama City University Medical Center
  • 1 - 1

Datasets

Release 1.2